New drug could cut transfusions for rare blood disorder
NCT ID NCT05664737
First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 3 times
Summary
This phase 2 trial tests luspatercept (Reblozyl) in adults and adolescents with alpha-thalassemia, a genetic blood disorder that causes anemia. The goal is to see if the drug can reduce the need for blood transfusions and raise hemoglobin levels. About 189 participants will receive either luspatercept or a placebo, plus standard care, to compare safety and effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- luspatercept (Reblozyl)
- What this could lead to
- If successful, this could offer a new treatment option to reduce blood transfusions and improve hemoglobin levels in people with alpha-thalassemia.
- What could go wrong
- This is a mid-stage trial, so results are not yet proven. The drug may not work for everyone, and side effects like hemolytic crises are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALPHA-THALASSEMIA HEMOGLOBIN H DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
"Universita degli Studi della Campania ""Luigi Vanvitelli"" - AOU - Clinica Pediatrica"
RECRUITINGNaples, 80138, Italy
-
China Medical University Hospital
RECRUITINGTaichung, TXG, 40447, Taiwan
-
Hacettepe Üniversitesi Tıp Fakültesi
RECRUITINGAltındağ, 06230, Turkey (Türkiye)
-
Hainan General Hospital
RECRUITINGHaikou, 570311, China
-
Hospital Sultanah Aminah
RECRUITINGJohor Bahru, 80100, Malaysia
-
Hospital Tunku Azizah
RECRUITINGKuala Lumpur, WP, 50586, Malaysia
-
Istanbul Universitesi - Istanbul Tip Fakultesi (ITF) Hastanesi
RECRUITINGTopkapı, 34093, Turkey (Türkiye)
-
KK Women's and Children's Hospital
RECRUITINGSingapore, 229899, Singapore
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
RECRUITINGKaohsiung City, KHH, 807, Taiwan
-
King Saud University (KSU) - College of Medicine
RECRUITINGRiyadh, 11411, Saudi Arabia
-
Liuzhou People's Hospital
RECRUITINGLiuzhou, Guangxi, 545006, China
-
Local Institution - 0005
WITHDRAWNThessaloniki, B, 546 42, Greece
-
Local Institution - 0006
COMPLETEDAthens, 115 27, Greece
-
Local Institution - 0007
ACTIVE_NOT_RECRUITINGLarissa, 26504, Greece
-
Local Institution - 0008
WITHDRAWNHalifax, Nova Scotia, B3K 6R8, Canada
-
Local Institution - 0009
ACTIVE_NOT_RECRUITINGGoudi, 11527, Greece
-
Local Institution - 0011
ACTIVE_NOT_RECRUITINGHaikou, Hainan, 570203, China
-
Local Institution - 0012
COMPLETEDKunming, Yunnan, 650032, China
-
Local Institution - 0018
ACTIVE_NOT_RECRUITINGRio, G, 265 04, Greece
-
Local Institution - 0020
ACTIVE_NOT_RECRUITINGOrbassano, TO, 10043, Italy
-
Local Institution - 0022
WITHDRAWNCagliari, CA, 09121, Italy
-
Local Institution - 0024
WITHDRAWNHong Kong Island, Hong Kong
-
Local Institution - 0025
COMPLETEDHong Kong, HK, Hong Kong
-
Local Institution - 0026
ACTIVE_NOT_RECRUITINGGenova, GE, 16128, Italy
-
Local Institution - 0028
ACTIVE_NOT_RECRUITINGNaples, 80131, Italy
-
Local Institution - 0035
WITHDRAWNAl-Ahsa, 31982, Saudi Arabia
-
Maoming People's Hospital
RECRUITINGMaoming Shi, Guangdong, 525000, China
-
Nanfang Hospital of Southern Medical University
RECRUITINGGuangzhou, GD, 510515, China
-
Naresuan University Hospital
RECRUITINGMueang Phitsanulok, 65000, Thailand
-
National Taiwan University Hospital
RECRUITINGNan Gang Qu, TPE, 10002, Taiwan
-
People's Liberation Army The 923rd Hospital
RECRUITINGNanning, GX, 530021, China
-
Shenzhen Second People's Hospital
RECRUITINGShenzhen Shi, Guangdong, 518025, China
-
Siriraj Hospital
RECRUITINGBangkok Noi, Bangkok, 10700, Thailand
-
Sun Yat-sen Memorial Hospital, Sun Yat-Sen University
RECRUITINGGuangzhou, GD, 510120, China
-
The First Affiliated Hospital of Guangxi Medical University
RECRUITINGNanning, 530021, China
-
The First People's Hospital of Foshan
RECRUITINGFoshan, Guangdong, 528000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can less be more? testing transfusion limits in ECMO
- A simple blood test trend may flag ICU patients at risk
- Rethinking anemia: does blood hemoglobin tell the whole story?
- A simple nutrient may shield Babies' brains from iron deficiency
- School health rooms and trained teachers: a new hope for Zambia's children?
- Can a pill replace EPO shots for anemia in kidney disease?